Manola Herrera-Cuellar

General Hospital Of México Dr. Eduardo Liceaga
Mexico City, DIF 06720, Mexico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Cannabidiol Modifies the Glutamate Over-Release in Brain Tissue of Patients and Rats with Epilepsy: A Pilot Study.

Cannabidiol Modifies the Glutamate Over-Release in Brain Tissue of Patients and Rats with Epilepsy: A Pilot Study.

Journal: Biomedicines
Published: November 01, 2023

Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence.

Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence.

Journal: International journal of molecular sciences
Published: October 29, 2022

Olfactory function in patients with temporal lobe epilepsy; correlation of functional magnetic resonance imaging for olfaction with the laterality of the epileptic focus.

Olfactory function in patients with temporal lobe epilepsy; correlation of functional magnetic resonance imaging for olfaction with the laterality of the epileptic focus.

Journal: Epilepsy research
Published: June 21, 2021

Optimizing deep brain stimulation for the treatment of drug-resistant temporal lobe epilepsy: a pilot study.

Optimizing deep brain stimulation for the treatment of drug-resistant temporal lobe epilepsy: a pilot study.

Journal: Journal of neurosurgery
Published: June 01, 2021

Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Journal: International journal of molecular sciences
Published: October 12, 2020

Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy.

Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy.

Journal: Frontiers in behavioral neuroscience
Published: September 28, 2020

Radiofrequency ablation of the centromedian thalamic nucleus in the treatment of drug-resistant epilepsy.

Radiofrequency ablation of the centromedian thalamic nucleus in the treatment of drug-resistant epilepsy.

Journal: Epilepsy & behavior : E&B
Published: June 24, 2020

Electrical Stimulation of Subiculum for the Treatment of Refractory Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis: A 2-Year Follow-Up Study.

Electrical Stimulation of Subiculum for the Treatment of Refractory Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis: A 2-Year Follow-Up Study.

Journal: Stereotactic and functional neurosurgery
Published: February 14, 2020

Activation of adenosine receptors modulates the efflux transporters in brain capillaries and restores the anticonvulsant effect of carbamazepine in carbamazepine resistant rats developed by window-pentylenetetrazole kindling.

Activation of adenosine receptors modulates the efflux transporters in brain capillaries and restores the anticonvulsant effect of carbamazepine in carbamazepine resistant rats developed by window-pentylenetetrazole kindling.

Journal: Brain research
Published: April 05, 2019

Quantitative Analysis of [18F]FFMZ and [18F]FDG PET Studies in the Localization of Seizure Onset Zone in Drug-Resistant Temporal Lobe Epilepsy.

Quantitative Analysis of [18F]FFMZ and [18F]FDG PET Studies in the Localization of Seizure Onset Zone in Drug-Resistant Temporal Lobe Epilepsy.

Journal: Stereotactic and functional neurosurgery
Published: March 30, 2019

Pharmacoresistant temporal lobe epilepsy modifies histamine turnover and H3 receptor function in the human hippocampus and temporal neocortex.

Pharmacoresistant temporal lobe epilepsy modifies histamine turnover and H3 receptor function in the human hippocampus and temporal neocortex.

Journal: Epilepsia
Published: January 08, 2016

Alterations of 5-HT1A receptor-induced G-protein functional activation and relationship to memory deficits in patients with pharmacoresistant temporal lobe epilepsy.

Alterations of 5-HT1A receptor-induced G-protein functional activation and relationship to memory deficits in patients with pharmacoresistant temporal lobe epilepsy.

Journal: Epilepsy research
Published: April 11, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026